Medications & Supplements/Prescription Drugs

Preferred Pharmaceuticals Alprazolam Tablets Recalled for Cross-Contamination

Agency Publication Date: April 5, 2023

Summary

Preferred Pharmaceuticals is recalling 383 bottles of Alprazolam (generic Xanax) tablets in 0.25mg, 0.5mg, and 1mg strengths. This recall was initiated due to potential cross-contamination issues during the manufacturing process at the Breckenridge Pharmaceuticals facility. No injuries or illnesses have been reported to date, but the manufacturer is voluntarily taking back affected units to ensure patient safety.

Risk

Cross-contamination occurs when traces of other medications or substances are accidentally mixed into a product during production. This can lead to patients ingesting unintended active ingredients, which could cause unpredictable side effects or dangerous drug interactions.

What You Should Do

This recall affects Alprazolam USP tablets (0.25mg, 0.5mg, and 1mg) sold under the Preferred Pharmaceuticals brand in 30, 60, and 90-count bottles.
Check your medication label for NDCs 68788-7594-3, 68788-7595-3, 68788-7595-6, 68788-7595-9, 68788-7596-3, or 68788-7596-6.
Check the lot number and expiration date printed on your bottle to see if it matches affected codes like G1822K, D2022P, or H3122D. See the Affected Products section below for the full list of affected codes.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Preferred Pharmaceuticals for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional assistance.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Alprazolam Tablets, USP 0.25mg, (CIV)

Variants: 0.25mg, Tablet

Lot Numbers:

G1822K (Exp 5/31/2023)

NDC:

68788-7594-3

30-count bottle; Rx Only

Product: Alprazolam Tablets, USP 0.5mg, (CIV)

Variants: 0.5mg, Tablet

Lot Numbers:

D2022P (Exp 4/30/2023)

F1022Y (Exp 6/30/2023)

E2022 (Exp 6/30/2023)

I2822U (Exp 6/30/2023)

L2122W (Exp 8/31/2024)

L0522A (Exp 8/31/2024)

B0823J (Exp 11/31/2024)

L1522P (Exp 10/31/2024)

NDC:

68788-7595-3

68788-7595-6

68788-7595-9

Packaged in 30, 60, and 90-count bottles; Rx Only

Product: Alprazolam Tablets, USP 1mg, (CIV)

Variants: 1mg, Tablet

Lot Numbers:

H3122D (Exp 8/31/2024)

A1123R (Exp 8/31/2024)

L0522E (Exp 8/31/2024)

J2622H (Exp 8/31/2024)

I1622F (Exp 8/31/2024)

H2422E (Exp 8/31/2024)

NDC:

68788-7596-3

68788-7596-6

Packaged in 30 and 60-count bottles; Rx Only

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 92008

Status: Resolved

Manufacturer: Preferred Pharmaceuticals, Inc.

Sold By: Pharmacies

Manufactured In: United States

Units Affected: 3 products (30 Bottles; 320 x 30-count; 46 x 60-count; 10 x 90-count bottles; 33 x 30-count; 78 x 60-count bottles)

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Alprazolam USP tablets (0.25mg, 0.5mg, and 1mg) sold under the Preferred Pharmaceuticals brand in 30, 60, and 90-count bottles.

Check your medication label for NDCs 68788-7594-3, 68788-7595-3, 68788-7595-6, 68788-7595-9, 68788-7596-3, or 68788-7596-6.

Check the lot number and expiration date printed on your bottle to see if it matches affected codes like G1822K, D2022P, or H3122D. See the Affected Products section below for the full list of affected codes.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Preferred Pharmaceuticals for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional assistance.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Alprazolam Tablets, USP 0.25mg, (CIV)

Variants: 0.25mg, Tablet

Lot Numbers:

G1822K (Exp 5/31/2023)

NDC:

68788-7594-3

30-count bottle; Rx Only

Product: Alprazolam Tablets, USP 0.5mg, (CIV)

Variants: 0.5mg, Tablet

Lot Numbers:

D2022P (Exp 4/30/2023)

F1022Y (Exp 6/30/2023)

E2022 (Exp 6/30/2023)

I2822U (Exp 6/30/2023)

L2122W (Exp 8/31/2024)

L0522A (Exp 8/31/2024)

B0823J (Exp 11/31/2024)

L1522P (Exp 10/31/2024)

NDC:

68788-7595-3

68788-7595-6

68788-7595-9

Packaged in 30, 60, and 90-count bottles; Rx Only

Product: Alprazolam Tablets, USP 1mg, (CIV)

Variants: 1mg, Tablet

Lot Numbers:

H3122D (Exp 8/31/2024)

A1123R (Exp 8/31/2024)

L0522E (Exp 8/31/2024)

J2622H (Exp 8/31/2024)

I1622F (Exp 8/31/2024)

H2422E (Exp 8/31/2024)

NDC:

68788-7596-3

68788-7596-6

Packaged in 30 and 60-count bottles; Rx Only

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 92008

Status: Resolved

Manufacturer: Preferred Pharmaceuticals, Inc.

Sold By: Pharmacies

Manufactured In: United States

Units Affected: 3 products (30 Bottles; 320 x 30-count; 46 x 60-count; 10 x 90-count bottles; 33 x 30-count; 78 x 60-count bottles)

Distributed To: Nationwide